Work

Engineering dual-specificity PPM1D inhibitors to enhance therapeutic response and overcome chemoresistance in TP53-mutant malignancies

Year: 2025

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2025-5048

Authors: Peter Miller, Ygang Tang, David McKinney, Mikolaj Slabicki, Rishi Puram, Adam Sperling, Michelle Lee, Jennifer Roth, Alexandra Gould, Eugene Oh

Institutions: Massachusetts General Hospital, Broad Institute, Brigham and Women's Hospital

Language: English

Topic: Protein Tyrosine Phosphatases

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7108461930

Cites:

Cited by:

Related to: